CHEBI:90039 - cyclo(L-His-L-Pro)

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name cyclo(L-His-L-Pro)
ChEBI ID CHEBI:90039
ChEBI ASCII Name cyclo(L-His-L-Pro)
Definition A homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH).
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:41471
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C11H14N4O2
Net Charge 0
Average Mass 234.259
Monoisotopic Mass 234.11168
InChI InChI=1S/C11H14N4O2/c16-10-9-2-1-3-15(9)11(17)8(14-10)4-7-5-12-6-13-7/h5-6,8-9H,1-4H2,(H,12,13)(H,14,16)/t8-,9-/m0/s1
InChIKey NAKUGCPAQTUSBE-IUCAKERBSA-N
SMILES O=C1N2CCC[C@]2(C(=O)N[C@H]1CC=3NC=NC3)[H]
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) Found in blood serum (BTO:0000133). See: PubMed
Homo sapiens (NCBI:txid9606) Found in brain (BTO:0000142). See: PubMed
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): human blood serum metabolite
Any metabolite (endogenous or exogenous) found in human blood serum samples.
dopamine uptake inhibitor
A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake.
Application(s): dopamine uptake inhibitor
A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing cyclo(L-His-L-Pro) (CHEBI:90039) has functional parent L-histidine (CHEBI:15971)
cyclo(L-His-L-Pro) (CHEBI:90039) has functional parent L-proline (CHEBI:17203)
cyclo(L-His-L-Pro) (CHEBI:90039) has role anti-inflammatory agent (CHEBI:67079)
cyclo(L-His-L-Pro) (CHEBI:90039) has role dopamine uptake inhibitor (CHEBI:51039)
cyclo(L-His-L-Pro) (CHEBI:90039) has role human blood serum metabolite (CHEBI:85234)
cyclo(L-His-L-Pro) (CHEBI:90039) is a dipeptide (CHEBI:46761)
cyclo(L-His-L-Pro) (CHEBI:90039) is a homodetic cyclic peptide (CHEBI:24613)
cyclo(L-His-L-Pro) (CHEBI:90039) is a imidazoles (CHEBI:24780)
cyclo(L-His-L-Pro) (CHEBI:90039) is a pyrrolopyrazine (CHEBI:48337)
IUPAC Name
(3S,8aS)-3-[(1H-imidazol-5-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Synonyms Sources
cyclo(His-Pro) ChemIDplus
cyclo(histidyl-prolyl) ChEBI
cyclo(L-His-L-Pro) ChEBI
His-Pro-DKP ChEBI
histidyl-proline diketopiperazine ChEBI
histidyl-proline-diketopiperazine ChEBI
histidylproline diketopiperazine ChEBI
L,L-cyclo(histidylprolyl) ChEBI
L-His-L-Pro-DKP ChEBI
L-histidyl-L-proline diketopiperazine UniProt
Manual Xrefs Databases
CHQ PDBeChem
FDB022818 FooDB
HMDB0002053 HMDB
View more database links
Registry Number Type Source
53109-32-3 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15509170 PubMed citation Europe PMC
21364307 PubMed citation Europe PMC
22185821 PubMed citation Europe PMC
2501708 PubMed citation Europe PMC
2512185 PubMed citation Europe PMC
27529240 PubMed citation Europe PMC
29708066 PubMed citation Europe PMC
3003820 PubMed citation Europe PMC
30439413 PubMed citation Europe PMC
3102558 PubMed citation Europe PMC
3129742 PubMed citation Europe PMC
3251576 PubMed citation Europe PMC
3840081 PubMed citation Europe PMC
6248056 PubMed citation Europe PMC
6278283 PubMed citation Europe PMC
6398951 PubMed citation Europe PMC
6401750 PubMed citation Europe PMC
6672793 PubMed citation Europe PMC
7679984 PubMed citation Europe PMC
Last Modified
25 October 2022
General Comment
2019-11-04 Please note that the structure provided in HMDB and FooDB for histidylproline diketopiperazine is incorrect.